Data / Form D filings / BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.: Form D filings
BioNumerik Pharmaceuticals, Inc., a pharmaceuticals company in San Antonio, TX, filed 2 Form D notices with the SEC between 2010 and 2012. The latest, on November 8, 2012, reports $10.2 million sold of a $28.9 million offering to 3 investors.
Find out what BioNumerik Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8122 DATAPOINT DRIVE, SUITE 1250, San Antonio, TX, 78229
- Phone
- (210) 614-1701
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 895131
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 8, 2012 | New notice | $28,875,860 | $10,190,500 | $18,685,360 | 3 | Oct 24, 2012 | sec.gov |
| Nov 12, 2010 | New notice | $26,250,755 | $1,130,000 | $25,120,755 | 4 | Oct 29, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry R. Jacobson | Director | |
| Dennert O. Ware | Director | |
| James R. Leininger | Director | |
| Frederick H. Hausheer | Executive Officer, Director | |
| John W. Yarbro | Director | |
| Homer L. Pearce | Director | |
| Harry R. Kochat | Executive Officer | |
| David R. Margrave | Executive Officer | |
| Steve W. Carchedi | Director | |
| Stacey R. Bain | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Nov 5, 2012 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BioNumerik Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.